← Open Payments lookup

NPI 1508985359: Open Payments

NPI 1508985359. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$696 in 6 payments from 3 companies in 2025. Trend: 2023 $354 · 2024 $1,043 · 2025 $696

Food & beverage: $696
CompanyPaymentsAmount
Novo Nordisk Inc3$371
Abbott Laboratories2$168
Kestra Medical Technology Services, Inc.1$158

Products named: FREESTYLE LIBRE 3, Assure WCD, Ozempic, Wegovy.